# A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)

> **NCT06708286** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **CanSino Biologics Inc.** · enrollment: 1820 (actual)

## Conditions studied

- Diphtheria
- Tetanus
- Pertussis

## Interventions

- **BIOLOGICAL:** Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp))
- **BIOLOGICAL:** 23-valent Pneumococcal Polysaccharide Vaccine (PPV23)
- **BIOLOGICAL:** Tdcp
- **BIOLOGICAL:** PPV23
- **BIOLOGICAL:** Tdcp
- **BIOLOGICAL:** PPV23
- **BIOLOGICAL:** Tdcp
- **BIOLOGICAL:** PPV23
- **BIOLOGICAL:** Tdcp
- **BIOLOGICAL:** Diphtheria-tetanus-acellular pertussis vaccine (DTaP)

## Key facts

- **NCT ID:** NCT06708286
- **Lead sponsor:** CanSino Biologics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-20
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 1820 (ACTUAL)
- **Last updated:** 2025-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06708286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06708286, "A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06708286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*